Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study)

Table 4 Impact of quality of therapeutic practices and pre-dialysis nephrology care on HRQoL (N = 283 respondents)

	PCS12			MCS12			Symptoms/problems			Effects of kidney disease			Burden of kidney disease
	Mean*	SE	P	Mean*	SE	P	Mean*	SE	P	Mean*	SE	P	Mean*	SE	P
Quality of therapeutic practices	0.006	0.006	NS			0.05			NS			NS			NS
High				44.6	1.0	0.01
Moderate				42.8	0.7	0.13
Poor				40.8	1.3	ref.
Time since referral to a nephrologist			NS			NS			0.004			0.09			NS
>12 months							69.9	1.5	0.001	63.5	1.8	0.03
[4 - 12[							69.5	2.7	0.007	62.9	3.2	0.09
[1 - 4 [							59.0	3.2	ref.	55.1	3.9	ref.
Number of nephrology consultations			NS			NS			NS			NS			NS
6 or more
3 - 5
0 - 2

Abbreviations: HRQoL, health related quality of life; PCS, physical component summary; MCS, mental component summary; SE, standard error; NS, not significant.
*Model adjusted for age, gender, BMI, primary renal disease, presence of co-morbidity, and nephrology unit.

ISSN: 1477-7525